Improving perinatal depression care_ the massachusetts child psychiatry access project for moms (pdf download available) data recovery plan

Perinatal depression is common and associated with poor birth, infant and child outcomes. Data recovery fort lauderdale Screening for perinatal depression alone does not improve treatment rates or patient outcomes. Data recovery mac This paper describes the development, implementation and outcomes of a new and low-cost population-based program to help providers address perinatal depression, the Massachusetts Child Psychiatry Access Project (MCPAP) for Moms.

MCPAP for Moms builds providers’ capacity to address perinatal depression through (1) trainings and toolkits on depression screening, assessment and treatment; (2) telephonic access to perinatal psychiatric consultation for providers serving pregnant and postpartum women; and (3) care coordination to link women with individual psychotherapy and support groups.

In the first 18months, MCPAP for Moms enrolled 87 Ob/Gyn practices, conducted 100 trainings and served 1123 women.

Data recovery tools Of telephone consultations provided, 64% were with obstetric providers/midwives and 16% were with psychiatrists. Data recovery pro MCPAP for Moms costs $8.38 per perinatal woman per year ($0.70 per month) or $600,000 for 71,618 deliveries annually in Massachusetts.

The volume of encounters, number of women served and low cost suggest that MCPAP for Moms is a feasible, acceptable and sustainable approach that can help frontline providers effectively identify and manage perinatal depression.

The purpose of this review is to update readers on recent controversies and findings on the underlying biology and clinical management of peripartum depression.

Topics discussed include the discovery and replication of two epigenetic biomarkers of peripartum depression, two well controlled studies that do NOT find associations between in utero antidepressant exposure and cardiac defects and persistent pulmonary hypertension of the newborn and ongoing controversy on whether antidepressant use during pregnancy prevents peripartum depression and whether or not hormonal treatments have a place in the management of postpartum depression.

Peripartum depression, or depression during and/or immediately following pregnancy, is a unique psychiatric illness that not only may have unique biological underpinnings but demands unique and thoughtful approaches to management due to the developing neonate. Data recovery hardware A number of controversies exist in this area ranging from the recent terminology change in psychiatry’s Diagnostic and Statistical Manual from “postpartum” to “peripartum” depression, to the safety of antidepressant use during pregnancy, to whether or not antidepressants prevent or decrease peripartum depression. Data recovery free Research in this area is growing, and a number of exciting developments have occurred including the identification of two epigenetic biomarkers of peripartum depression that may eventually lead to early identification and intervention, the potential for hormonal treatments, and the recommendation for and early institution of universal screening for peripartum depression. Data recovery software reviews These topics are explored and put into context from a clinical management perspective.